CENTAGEN Trademark

Trademark Overview

On Friday, June 17, 2022, a trademark application was filed for CENTAGEN with the United States Patent and Trademark Office. The USPTO has given the CENTAGEN trademark a serial number of 97464407. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, August 14, 2025. This trademark is owned by Centagen, Inc.. The CENTAGEN trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations for the treatment of age-related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Therapeutic pharmaceutical for the treatment of age-related diseases and disorders; Therapeutic pharmaceutical for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Cardiovascular pharmaceutical preparations
centagen

General Information

Serial Number97464407
Word MarkCENTAGEN
Filing DateFriday, June 17, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, August 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Goods and ServicesCardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations for the treatment of age-related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Therapeutic pharmaceutical for the treatment of age-related diseases and disorders; Therapeutic pharmaceutical for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Cardiovascular pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCentagen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80305
Party NameCentagen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80305

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022NEW APPLICATION ENTERED
Wednesday, July 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 29, 2023ASSIGNED TO EXAMINER
Wednesday, March 29, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 29, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 12, 2023ASSIGNED TO LIE
Monday, November 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 12, 2024SOU EXTENSION 1 FILED
Monday, August 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 12, 2025SOU EXTENSION 2 FILED
Thursday, February 13, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, September 3, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 16, 2025SOU EXTENSION 2 GRANTED
Tuesday, September 16, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, September 16, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 16, 2025CORRECTED NOA E-MAILED
Wednesday, September 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 17, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, April 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 13, 2025SOU TEAS EXTENSION RECEIVED
Thursday, February 13, 2025TEAS REQUEST TO DIVIDE RECEIVED

Related Keywords

centagen pharmaceutical cardiovascular treatment disorders related diseases preparations inflammatory therapeutic system